Han‐Tan Chai

About

Dr. Han-Tan Chai is a clinician-researcher whose work bridges otolaryngology and cardiovascular risk, with a primary focus on obstructive sleep apnea (OSA). His most cited study, "Homocysteine Levels in Severe OSA Patients Before and After TORS-OSA Surgery" (2023, 9 citations), investigates the link between OSA and elevated serum homocysteine—a known cardiovascular disease marker. This work demonstrates that transoral robotic surgery for OSA (TORS-OSA) may reduce homocysteine levels, suggesting a potential pathway for mitigating cardiovascular comorbidities in severe OSA patients. By exploring surgical interventions' systemic effects, Dr. Chai contributes to a growing understanding of how treating upper airway obstruction can influence broader metabolic and vascular health. His research is particularly notable for integrating surgical outcomes with biochemical markers, offering a novel perspective on OSA management. While his citation count reflects an emerging career, the clinical relevance of his findings—especially the intersection of sleep surgery and cardiovascular risk reduction—positions him as a promising voice in otolaryngology and sleep medicine, with implications for both surgical practice and preventive cardiology.

Research Focus

Key Achievements

Top Papers

1. 1
   Homocysteine Levels in Severe OSA Patients Before and After TORS‐OSA Surgery

   9 citations · 2023

Key Collaborators

Contact & Links